Meta-analysis of risk factors for peptic ulcer: Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking

Journal of Clinical Gastroenterology

Volumn 24, Issue 1, 1997, Pages 2-17

  Kurata, John H ^a,b,d   Nogawa, Aki N ^a,c  

^a San Bernardino County Medical Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Research and Policy Analysis   (United States)

Author keywords

Attributable risk; H. pylori; Meta analysis; NSAID; Peptic ulcer; Smoking

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CALCULATION; CIGARETTE SMOKING; DRUG USE; FEMALE; HELICOBACTER PYLORI; HUMAN; MALE; PEPTIC ULCER; PRIORITY JOURNAL; RISK FACTOR;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DATA COLLECTION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MODELS, THEORETICAL; PEPTIC ULCER; RISK FACTORS; SMOKING;

EID: 0031031977     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199701000-00002     Document Type: Article

References (95)

1. Pincus T, Griffin M. Gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs: new insights from observational studies and functional status questionnaires [Editorial]. Am J Med 1991;91:209-12.
2. Faulkner G, Prichard P, Somerville K, Langman MJS. Aspirin and bleeding peptic ulcers in the elderly. BMJ 1988;297:1311-3.
3. Griffin MR, Ray WA, Schaffner W. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 1988;109:359-63.
4. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991;114: 257-63.
5. Henry D, Dobson A, Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 1993;105:1078-88.
6. Somerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986;1: 462-4.
7. Carson JL, Strom BL, Soper KA, West SL, Morse ML. The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med 1987;147:85-8.
8. Holvoet J, Terriere L, Van Hee W, Verbist L, Fierens E, Hautekeete ML. Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study. Gut 1991;32:730-4.
9. Kurata JH, Elashoff JD, Nogawa AN, Haile BM. Sex and smoking differences in duodenal ulcer mortality. Am J Public Health 1986;76:700-2.
10. Isenberg JI, McQuaid KR, Laine L, Walsh JH. Acid-peptic disorders. In: Yamada T, ed. Textbook of gastroenterology. Vol. 1. 2nd ed. Philadelphia: Lippincott, 1995:1347-430.
11. Kurata JH. Epidemiology: peptic ulcer risk factors. Semin Gastrointest Dis 1993;4:2-12.
12. Soll AH. Gastric, duodenal, and stress ulcer. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal disease: pathophysiology, diagnosis, management. Vol. 1. 5th ed. Philadelphia: Saunders, 1993:580-679.
13. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987;9:1-30.
14. Lilienfeld AM, Lilienfeld DE. Foundations of epidemiology. 2nd ed. New York: Oxford University Press, 1980:166-83,217-8,342-7.
15. Mausner JS, Kramer S. Epidemiology: an introductory text. Philadelphia: Saunders, 1985:119-51.
16. National Center for Health Statistics. Health, United States, 1994. Hyattsville: Public Health Service, 1995.
17. Graham DY, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991;100:1495-501.
18. Bloom BS. Risk and cost of gastrointestinal side effects associated with nonsteroidal anti-inflammatory drugs. Arch Intern Med 1989;149:1019-22.
19. U.S. Bureau of the Census. U.S. population estimates by age, sex, race, and Hispanic origin: 1980 to 1991. Current population reports, series P-25, no. 1095. Washington: U.S. Government Printing Office, Feb. 1993:90-3.
20. Hennekens CH, Buring JE. Epidemiology in medicine. Boston: Little, Brown, 1987.
21. Bollini P, Garcia Rodriguez LA, Gutthann SP, Walker AM. The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease. Arch Intern Med 1992;152:1289-95.
22. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991; 115:787-96.
23. Willett LR, Carson JL, Strom BL. Epidemiology of gastro-intestinal damage associated with nonsteroidal anti-inflammatory drugs. Drug Safety 1994;10:170-81.
24. Langman MJS, Coggon D, Spiegelhalter D. Analgesic intake and the risk of acute upper gastrointestinal bleeding. Am J Med 1983;74:79-82.
25. Alexander AM, Veitch GBA, Wood JB. Anti-rheumatic and analgesic drug usage and acute gastro-intestinal bleeding in elderly patients. J Clin Hosp Pharm 1985;10:89-93.
26. Armstrong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut 1987;28:527-32.
27. Bartle WR, Gupta AK, Lazor J. Nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding. A case-control study. Arch Intern Med 1986;146:2365-7.
28. Caradoc-Davies TH. Nonsteroidal anti-inflammatory drugs, arthritis, and gastro-intestinal bleeding in elderly in-patients. Age Aging 1984;13:295-8.
29. Collier D StJ, Pain JA. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 1985;26:359-63.
30. Garcia Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:769-72.
31. Kaufman DW, Kelly JP, Sheehan JE, et al. Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther 1993;53:485-94.
32. Lanas A, Sekar MC, Hirschowitz BI. Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastro-intestinal bleeding. Gastroenterology 1992;103:862-9.
33. Langman MJS, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:1075-8.
34. Laporte J-R, Carne X, Vidai X, Moreno V, Juan J, Catalan Countries Study on Upper Gastrointestinal Bleeding. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Lancet 1991;337: 85-9.
35. Levy M, Miller DR, Kaufman DW, et al. Major upper gastro-intestinal tract bleeding. Relation to the use of aspirin and other nonnarcotic analgesics. Arch Intern Med 1988;148:281-5.
36. Savage RL, Moller PW, Ballantyne CL, Wells JE. Variation in the risk of peptic ulcer complications with nonsteroidal anti-inflammatory drug therapy. Arthritis Rheum 1993;36:84-90.
37. Smedley FH, Taube M, Leach R, Wastell C. Non-steroidal anti-inflammatory drug ingestion: retrospective study of 272 bleeding or perforated peptic ulcers. Postgrad Med 1989;65:892-5.
38. Fries JF, Williams CA, Bloch DA, Michel BA. Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med 1991;91:213-22.
39. Smalley WE, Ray WA, Daugherty JR, Griffin MR. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol 1995;141:539-45.
40. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 1992;327:749-54.
41. Beard K, Walker AM, Perera DR, Jick H. Nonsteroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly. Arch Intern Med 1987;147:1621-3.
42. Beardon PHG, Brown SV, McDevitt DG. Gastrointestinal events in patients prescribed non-steroidal anti-inflammatory drugs: a controlled study using record linkage in Tayside. Q J Med 1989;71:497-505.
43. Garcia Rodriguez LA, Walker AM, Gutthann SP. Nonsteroidal antiinflammatory drugs and gastrointestinal hospitalizations in Saskatchewan: a cohort study. Epidemiology 1992;3:337-42.
44. Guess HA, West R, Strand LM, et al. Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of non-steroidal anti-inflammatory drugs in Saskatchewan, Canada 1983. J Clin Epidemiol 1988;41:33-45.
45. Jick H, Feld AD, Perera DR. Certain nonsteroidal antiinflammatory drugs and hospitalization for upper gastrointestinal bleeding. Phamacotherapy 1985;5:280-4.
46. Jick SS, Perera DR, Walker AM, Jick H. Non-steroidal anti-inflammatory drugs and hospital admission for perforated peptic ulcer. Lancet 1987;2:380-2.
47. Cairns JA, Gent M, Singer J, et al. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. N Engl J Med 1985;313:1369-75.
48. Juul-Moller S, Edvardsson N, Jahnmatz B, et al. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. Lancet 1992; 340:1421-5.
49. Kurata JH, Abbey DE. The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations. J Clin Gastroenterol 1990;12:260-6.
50. Persantine-Aspirin Reinfarction Study Research Group. Persantine and aspirin in coronary heart disease. Circulation 1980; 62:449-61.
51. SALT Collaborative Group. Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet 1991;338:1345-9.
52. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321:129-35.
53. UK-TIA Study Group. United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. BMJ 1988;296: 316-20.
54. Baum C, Kennedy DL, Forbes MB. Utilization of nonsteroidal antiinflammatory drugs. Arthritis Rheum 1985;28:686-92.
55. National Center for Health Statistics, Koch H, Knapp DA. Highlights of drug utilization in office practice. National Ambulatory Medical Care Survey, 1985. Advance data from vital and health statistics, no. 134. DHHS pub. no. (PHS) 87-1250. Hyattsville: Public Health Service, 1987.
56. Schappert SM. National Ambulatory Medical Care Survey, 1991 summary. National Center for Health Statistics. Vital and health statistics, series 13, no. 116. DHHS pub. no. (PHS) 94-1777. Hyattsville: Public Health Service, 1994.
57. Schappert SM. National Ambulatory Medical Care Survey, 1992 summary. National Center for Health Statistics. Advance data from vital and health statistics, no. 253. DHHS pub. no. (PHS) 94-1250. Hyattsville: Public Health Service, 1994.
58. Martin DF, Montgomery E, Dobek AS, Patrissi GA, Peura DA. Campylobacter pylori, NSAIDS, and smoking: risk factors for peptic ulcer disease. Am J Gastroenterol 1989;84:1268-72.
59. Blaser MJ, Chyou PH, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 1995;55:562-5.
60. 13C] urea breath test in normal subjects and patients with peptic ulcer disease. J Infect Dis 1988;157:777-80.
61. Parsonnet J, Blaser MJ, Perez-Perez GI, Hargrett-Bean N, Tauxe RV. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology 1992;102: 41-6.
62. Parsonnet J. Gastric adenocarcinoma and Helicobacter pylori infection [Editorial]. West J Med 1994;161:60.
63. Schubert TT, Bologna SD, Nensey Y, Schubert AB, Mascha EJ, Ma CK. Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use, and age. Am J Med 1993;94:413-8.
64. Kim JG, Graham DY, Misoprostol Study Group. Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy. Am J Gastroenterol 1994;89:203-7.
65. Leoci C, Ierardi E, Chiloiro M, et al. Incidence and risk factors of duodenal ulcer. A retrospective cohort study. J Clin Gastroenterol 1995;20:104-9.
66. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
67. Taha AS, Sturrock RD, Russell RI. Mucosal erosions in long-term non-steroidal anti-inflammatory drug users: predisposition to ulceration and relation to Helicobacter pylori. Gut 1995;36: 334-6.
68. Dooley CP, Cohen H, Fitzgibbons PL, et al. Prevalence of Helicobacter pylon infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989;321:1562-6.
69. Graham DY, Adam E, Klein PD, et al. Comparison of the prevalence of asymptomatic C. pylori infection in the United States: effect of age, gender, and race [Abstract]. Gastroenterology 1989;96:A180.
70. Faisal MA, Santogade PJ, Russell RM, Samloff IM, Holt PR. Atrophic gastritis of the elderly. Evidence against a role for C. pylori infection [Abstract]. Gastroenterology 1989;96: A121.
71. Attar B, Go B, Kocka F, Levendoglu H. The incidence of C. pylori infection among patients of a GI-endoscopy unit in a metropolitan hospital [Abstract]. Gastroenterology 1988;94:A14.
72. Malaty HM, Evans DG, Evans DJ Jr, Graham DY. Helicobacter pylori in hispanics: comparison with blacks and whites of similar age and socioeconomic class. Gastroenterology 1992; 103:813-6.
73. Kurata JH, Nogawa AN, Abbey DE, Petersen F. A prospective study of risk for peptic ulcer disease in Seventh-Day Adventists. Gastroenterology 1992;102:902-9.
74. McIntosh JH, Byth K, Piper DW. Environmental factors in aetiology of chronic gastric ulcer: a case control study of exposure variables before the first symptoms. Gut 1985;26:789-98.
75. McIntosh JH, Fung CS, Berry G, Piper DW. Smoking, non-steroidal anti-inflammatory drugs, and acetaminophen in gastric ulcer. A study of associations and the effects of previous diagnosis on exposure patterns. Am J Epidemiol 1988;128:761-70.
76. Alp MH, Hislop IG, Grant AK. Gastric ulcer in South Australia 1954-1963. 1. Epidemiological factors. Med J Aust 1970; 2:1128-32.
77. Farah D, Sturrock RD, Russell RI. Peptic ulcer in rheumatoid arthritis. Ann Rheum Dis 1988;47:478-80.
78. Gillies MA, Skyring A. Gastric and duodenal ulcer. The association between aspirin ingestion, smoking, and family history of ulcer. Med J Aust 1969;2:280-5.
79. Kasanen A, Forsstrom J. Social stress and living habits in the etiology of peptic ulcer. Ann Med Int Fenn 1966;55:13-22.
80. Kaufmann D, Wilder-Smith CH, Kempf M, et al. Cigarette smoking, gastric acidity, and peptic ulceration. What are the relationships? Dig Dis Sci 1990;35:1482-7.
81. Monson RR. Cigarette smoking and body form in peptic ulcer. Gastroenterology 1970;58:337-43.
82. Ostensen H, Gudmundsen TE, Ostensen M, Burhol PG, Bonnevie O. Smoking, alcohol, coffee, and familial factors: any associations with peptic ulcer disease? A clinically and radiologically prospective study. Scand J Gastroenterol 1985; 20:1227-35.
83. Piper DW, McIntosh JH, Greig M, Shy CM. Environmental factors and chronic gastric ulcer. A case control study of the association of smoking, alcohol, and heavy analgesic ingestion with the exacerbation of chronic gastric ulcer. Scand J Gastroenterol 1982;17:721-9.
84. Piper DW, Nasiry R, McIntosh J, Shy CM, Pierce J, Byth K. Smoking, alcohol, analgesics, and chronic duodenal ulcer. A controlled study of habits before first symptoms and before diagnosis. Scand J Gastroenterol 1984;19:1015-21.
85. Watanabe Y, Kurata JH, Kawamoto K, Kawai K. Epidemiological study of peptic ulcer disease among Japanese and Koreans in Japan. J Clin Gastroenterol 1992;15:68-74.
86. Anda RF, Williamson DF, Escobedo LG, Remington PL. Smoking and the risk of peptic ulcer disease among women in the United States. Arch Intern Med 1990;150:1437-41.
87. Goldbourt U, Medalie JH. Characteristics of smokers, nonsmokers, and ex-smokers among 10,000 adult males in Israel. I. Distribution of selected sociodemographic and behavioral variables and the prevalence of disease. Israel J Med Sci 1975;11:1079-101.
88. Paffenbarger RS Jr, Wing AL, Hyde RT. Chronic disease in former college students. XIII. Early precursors of peptic ulcer. Am J Epidemiol 1974;100:307-15.
89. Schoon IM, Mellstrom D, Oden A, Ytterberg BO. Peptic ulcer disease in older age groups in Gothenburg in 1985: the association with smoking. Age Aging 1991;20:371-6.
90. Stemmermann GN, Marcus EB, Buist AS, MacLean CJ. Relative impact of smoking and reduced pulmonary function on peptic ulcer risk. A prospective study of Japanese men in Hawaii. Gastroenterology 1989;96:1419-24.
91. Replogle ML, Glaser SL, Hiatt RA, Parsonnet J. Biologic sex as a risk factor for Helicobacter pylori infection in healthy young adults. Am J Epidemiol 1995;142:856-63.
92. Harrison AR, Elashoff JD, Grossman MI. Peptic ulcer disease. In: Smoking and health: a report of the Surgeon General. DHEW pub. no. (PHS) 79-50066. Hyattsville: Public Health Service, 1979 9-3-9-21.
93. U.S. Public Health Service. Peptic ulcer. In: The health consequences of smoking. A report of the Surgeon General: 1971. DHEW pub. no. (HSM) 71-7513. Washington: Public Health Service, 1971:421-30.
94. Wang J-Y, Liu S-B, Chen S-Y, Dobson A. Risk factors for peptic ulcer in Shanghai. Int J Epidemiol 1996;25:638-43.
95. Kurata JH. An assessment of nonsteroidal anti-inflammatory drugs as a risk factor in ulcer disease. Ann Intern Med 1991; 114:311-5.